**Core Concept**
Anti-transglutaminase antibodies are a type of autoantibody directed against tissue transglutaminase, an enzyme involved in protein cross-linking and modification. These antibodies are a key marker for celiac disease, an autoimmune disorder triggered by gluten consumption.

**Why the Correct Answer is Right**
In celiac disease, the ingestion of gluten leads to an immune response, resulting in the production of anti-transglutaminase antibodies. These antibodies recognize and bind to tissue transglutaminase, which is found in the small intestine. This binding causes the enzyme to be inactivated, leading to a deficiency in essential amino acids and impaired nutrient absorption. The presence of anti-transglutaminase antibodies is a diagnostic hallmark of celiac disease, and their detection is often used to screen for the condition.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because anti-transglutaminase antibodies are not typically associated with rheumatoid arthritis, which is characterized by autoantibodies against collagen, cyclic citrullinated peptides, or other joint-related antigens.

**Option B:** This option is incorrect because anti-smooth muscle antibodies are more commonly associated with autoimmune hepatitis, where they target smooth muscle cells in the liver.

**Option C:** This option is incorrect because anti-nuclear antibodies (ANA) are a broad category of autoantibodies that can be present in various autoimmune diseases, including systemic lupus erythematosus, but are not specific to celiac disease.

**Clinical Pearl / High-Yield Fact**
Celiac disease can present with a wide range of symptoms, including diarrhea, abdominal pain, fatigue, and weight loss, but some patients may be asymptomatic. The presence of anti-transglutaminase antibodies can help diagnose celiac disease in patients with or without symptoms.

**Correct Answer:** D. Celiac disease